Mycosis Fungoides Treatment Global Market Report 2025
상품코드:1825828
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
균상식육종 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 13억 1,000만 달러로 성장할 것이며, 연평균 6.2%의 성장률을 보일 것입니다. 예측 기간의 성장은 의료 인프라의 발전, 환자 인구의 증가, 비위생적인 생활 습관으로 인한 곰팡이성 호흡기질환의 유병률 증가에 기인합니다. 예측 기간의 주요 동향으로는 화학요법에 따른 치료기술의 발전, 1차 치료제로서의 단클론항체 수요 증가, 첨단 신제품 출시, 연구개발 투자 증가 등을 꼽을 수 있습니다.
향후 5년간 6.2%의 성장률 전망은 지난번 예측보다 0.6% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스위스나 이스라엘에서 개발된 광페리시스 시스템이나 표적 단클론항체의 가격을 급등시켜 피부 T세포 림프종 관리가 늦어지고 피부과 전문의 비용이 상승하여 미국 피부과 의료에 지장을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
림프종 발병률의 증가는 향후 균상식육종 치료 시장 확대를 견인할 것으로 예상됩니다. 림프절, 비장, 흉선, 골수로 구성된 림프계에 영향을 미치는 암인 림프종은 환경 노출, 바이러스 감염, 고령화, 생활습관 등 다양한 요인으로 인해 증가 추세에 있습니다. 균상식육종 치료는 국소 코르티코스테로이드, 광선요법, 전신요법 등이 있으며, 피부 T세포 림프종 관리에서 피부 병변의 조절, 증상 완화, 림프종 환자의 질병 진행을 관리하는 데 활용되고 있습니다. 예를 들어, 2024년 1월 미국암학회에 따르면 비호지킨림프종(NHL)은 미국에서 가장 발병률이 높은 암 중 하나이며, 전체 암 사례의 약 4%를 차지합니다. 2024년에는 약 80,620명(남성 44,590명, 여성 36,030명)이 비호지킨림프종으로 진단받고, 약 20,140명(남성 11,780명, 여성 8,360명)이 이 암으로 사망할 것으로 추정됩니다. 따라서 림프종 발병률의 증가는 균상식육종 치료 시장의 성장에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 균상식육종 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 균상식육종 치료 시장 : 성장률 분석
세계의 균상식육종 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 균상식육종 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 균상식육종 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 균상식육종 치료 시장 : 약제 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
국소 스테로이드
메클로레타민
세계의 균상식육종 치료 시장 : 치료 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
광역학 요법
방사선 치료
표적요법
화학요법
세계의 균상식육종 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
개인 클리닉
전문 클리닉
세계의 균상식육종 치료 시장 : 하위 세분화 국소 스테로이드(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
코르티코스테로이드 크림 또는 연고(하이드로코르티손, 클로베타솔)
국소 스테로이드 로션
세계의 균상식육종 치료 시장 : 하위 세분화 메클로레타민(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
국소용 메클로레타민(질소 머스타드 크림)
주사용 메클로레타민
제7장 지역별·국가별 분석
세계의 균상식육종 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 균상식육종 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
균상식육종 치료 시장 : 경쟁 구도
균상식육종 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Bristol Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
GlaxoSmithKline plc
Tocris Bioscience
Viatris Inc.
Astellas Pharma Inc.
Daiichi Sankyo Company
Takeda Pharmaceutical Company Limited
Bausch Health
Eisai Co. Ltd.
Horizon Therapeutics plc
Varian Medical Systems
Kyowa Kirin Co. Ltd.
Seattle Genetics Inc.
Azurity Pharmaceuticals Inc.
Innate Pharma S.A.
Helsinn Therapeutics
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
균상식육종 치료 시장 2029 : 새로운 기회를 제공하는 국가
균상식육종 치료 시장 2029 : 새로운 기회를 제공하는 부문
균상식육종 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Mycosis fungoides treatment encompasses a range of therapies, medications, and procedures aimed at managing and alleviating symptoms associated with cutaneous T-cell lymphoma, a rare type of non-Hodgkin lymphoma primarily affecting the skin. Treatment approaches typically involve a combination of therapies, including topical medications and systemic treatments such as immunotherapy, tailored to the specific stage and severity of the disease.
The primary types of mycosis fungoides treatment include topical steroids and mechlorethamine. Topical steroids are applied directly to the skin to reduce inflammation and irritation. Other treatment modalities encompass photodynamic therapy, radiation therapy, targeted therapy, and chemotherapy, utilized across various healthcare settings such as hospitals, private clinics, and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The mycosis fungoides treatment market research report is one of a series of new reports from The Business Research Company that provides mycosis fungoides treatment market statistics, including mycosis fungoides treatment industry global market size, regional shares, competitors with a mycosis fungoides treatment market share, detailed mycosis fungoides treatment market segments, market trends and opportunities, and any further data you may need to thrive in the mycosis fungoides treatment industry. This mycosis fungoides treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mycosis fungoides treatment market size has grown strongly in recent years. It will grow from $0.97 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased incidences of immune system dysfunction, inflating utilization of efficacious therapeutics, widespread adoption of phototherapy, rise in usage of radiation therapy, and the increased popularity of supportive care measures.
The mycosis fungoides treatment market size is expected to see strong growth in the next few years. It will grow to $1.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to advancements in healthcare infrastructure, increasing patient population, and increase in prevalence of mycosis fungoides due to unhygienic lifestyles. Major trends in the forecast period include technological advancements in treatment associated with chemotherapy, a rise in demand for monoclonal antibodies as first-line therapy, the launch of new advanced products, and increasing investment in research and development.
The forecast of 6.2% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. dermatology care by inflating prices of photopheresis systems and targeted monoclonal antibodies developed in Switzerland and Israel, resulting in delayed cutaneous T-cell lymphoma management and higher specialty dermatology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of lymphoma cancer is expected to drive the expansion of the mycosis fungoides treatment market in the future. Lymphoma, a cancer affecting the lymphatic system comprising lymph nodes, spleen, thymus gland, and bone marrow, is on the rise due to various factors such as environmental exposures, viral infections, an aging population, and lifestyle choices. Mycosis fungoides treatments, including topical corticosteroids, phototherapy, and systemic therapies, are utilized in managing cutaneous T-cell lymphomas to control skin lesions, alleviate symptoms, and manage disease progression in lymphoma patients. For example, in January 2024, according to the American Cancer Society, non-Hodgkin lymphoma (NHL) ranked among the most prevalent cancers in the United States, constituting about 4% of all cancer cases. It was estimated that around 80,620 individuals (44,590 males and 36,030 females) would be diagnosed with NHL, with approximately 20,140 people (11,780 males and 8,360 females) succumbing to this cancer in 2024. Hence, the increasing incidence of lymphoma cancer is fueling the growth of the mycosis fungoides treatment market.
Key players in the mycosis fungoides treatment market are focusing on developing advanced therapies such as CAR T cell therapy to enhance treatment efficacy and specificity. CAR T cell therapy, a form of immunotherapy, involves genetically modifying a patient's T cells to better recognize and target cancer cells, including those associated with mycosis fungoides. For instance, in September 2022, CRISPR Therapeutics AG, a Switzerland-based biotech company, announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX130, the company's allogeneic CAR T cell therapy targeting CD70, for treating Mycosis Fungoides and Sezary Syndrome (MF or SS). This designation signifies a significant milestone for the CTX130 program, acknowledging the potential of this cell therapy in treating T-cell lymphomas based on promising clinical data. The RMAT designation is part of a program established under the 21st Century Cures Act to expedite drug development and review processes for genetic therapies intended to treat severe or life-threatening diseases.
In October 2023, Shorla Oncology, an Ireland-based pharmaceutical company, acquired Jylamvo from Therakind for an undisclosed amount. This acquisition allows Shorla to introduce Jylamvo to the US market, where it has been approved for treating conditions such as acute lymphoblastic leukemia and mycosis fungoides. Therakind Limited, a UK-based pharmaceutical company, specializes in developing niche medicines.
Major companies operating in the mycosis fungoides treatment market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Tocris Bioscience, Viatris Inc., Astellas Pharma Inc., Daiichi Sankyo Company, Takeda Pharmaceutical Company Limited, Bausch Health, Eisai Co. Ltd., Horizon Therapeutics plc, Varian Medical Systems, Kyowa Kirin Co. Ltd., Seattle Genetics Inc., Azurity Pharmaceuticals Inc., Innate Pharma S.A., Helsinn Therapeutics, Jubilant Cadista Pharmaceuticals Inc., Elorac Inc., Soligenix Inc., Ceptaris Therapeutics Inc.
North America was the largest region in the mycosis fungoides treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mycosis fungoides treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mycosis fungoides treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mycosis fungoides treatment market consists of revenues earned by entities by providing services, such as phototherapy, dermatological care, and specialized therapies. The market value includes the value of related services provided by the treatment creators or included within the treatment offering. The mycosis fungoides treatment market also includes sales of oral retinoids, interferons, monoclonal antibodies, and nitrogen mustard. Values in this market are 'factory gate' values, that is, the value of treatments sold by the manufacturers or creators of the treatments, whether to other entities (including downstream healthcare providers and pharmacies) or directly to end customers. The value of treatments in this market includes related services sold by the creators of the treatments.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mycosis Fungoides Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mycosis fungoides treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mycosis fungoides treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mycosis fungoides treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Type: Topical Steroids; Mechlorethamine
3. Mycosis Fungoides Treatment Market Trends And Strategies
4. Mycosis Fungoides Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Mycosis Fungoides Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Mycosis Fungoides Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mycosis Fungoides Treatment Market Growth Rate Analysis
5.4. Global Mycosis Fungoides Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mycosis Fungoides Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mycosis Fungoides Treatment Total Addressable Market (TAM)
6.1. Global Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Steroids
Mechlorethamine
6.2. Global Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Photodynamic Therapy
Radiation Therapy
Targeted Therapy
Chemotherapy
6.3. Global Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Private Clinics
Specialty Clinics
6.4. Global Mycosis Fungoides Treatment Market, Sub-Segmentation Of Topical Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroid Creams Or Ointments (Hydrocortisone, Clobetasol)
Topical Steroid Lotions
6.5. Global Mycosis Fungoides Treatment Market, Sub-Segmentation Of Mechlorethamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Mechlorethamine (Nitrogen Mustard Cream)
Injectable Mechlorethamine
7. Mycosis Fungoides Treatment Market Regional And Country Analysis
7.1. Global Mycosis Fungoides Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mycosis Fungoides Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Mycosis Fungoides Treatment Market
9.1. China Mycosis Fungoides Treatment Market Overview
9.2. China Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Mycosis Fungoides Treatment Market
10.1. India Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Mycosis Fungoides Treatment Market
11.1. Japan Mycosis Fungoides Treatment Market Overview
11.2. Japan Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Mycosis Fungoides Treatment Market
12.1. Australia Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Mycosis Fungoides Treatment Market
13.1. Indonesia Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Mycosis Fungoides Treatment Market
14.1. South Korea Mycosis Fungoides Treatment Market Overview
14.2. South Korea Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Mycosis Fungoides Treatment Market
15.1. Western Europe Mycosis Fungoides Treatment Market Overview
15.2. Western Europe Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Mycosis Fungoides Treatment Market
16.1. UK Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Mycosis Fungoides Treatment Market
17.1. Germany Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Mycosis Fungoides Treatment Market
18.1. France Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Mycosis Fungoides Treatment Market
19.1. Italy Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Mycosis Fungoides Treatment Market
20.1. Spain Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Mycosis Fungoides Treatment Market
21.1. Eastern Europe Mycosis Fungoides Treatment Market Overview
21.2. Eastern Europe Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Mycosis Fungoides Treatment Market
22.1. Russia Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Mycosis Fungoides Treatment Market
23.1. North America Mycosis Fungoides Treatment Market Overview
23.2. North America Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Mycosis Fungoides Treatment Market
24.1. USA Mycosis Fungoides Treatment Market Overview
24.2. USA Mycosis Fungoides Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Mycosis Fungoides Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Mycosis Fungoides Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
